Mimedx (MDXG) FCF Margin (2011 - 2026)

Mimedx (MDXG) reported FCF Margin of 2.22% for Q1 2026, down 336.0% on a YoY basis from 0.94% in Q1 2025, and down 89.38% sequentially from 20.89% in Q4 2025.

Mimedx (MDXG) FCF Margin (2011 - 2026) Analysis & Trends

Mimedx (MDXG) has 16 years of FCF Margin data on file, last reported at 2.22% in Q1 2026.

  • For the quarter ending Q1 2026, FCF Margin fell 336.0% year-over-year to 2.22%; the trailing twelve-month figure through Mar 2026 stood at 17.81% (down 79.0% YoY), and the FY2025 full-year result was 17.43%, down 133.0% from the prior year.
  • FCF Margin retreated to 2.22% in Q1 2026, from 20.89% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 25.62% in Q3 2025 to a low of 17.56% in Q1 2022.
  • A 5-year average of 9.25% and a median of 5.71% in 2024 frame the typical range for FCF Margin.
  • Across the five-year window, FCF Margin soared 2741 bps in 2022 and slumped 1045 bps in 2025, its largest moves.
  • Tracing MDXG's FCF Margin over 5 years: stood at 4.88% in 2022, then plunged by 121 bps to 1.01% in 2023, then surged by 2069 bps to 19.93% in 2024, then advanced by 5 bps to 20.89% in 2025, then plunged by 89 bps to 2.22% in 2026.
  • Business Quant data shows MDXG's FCF Margin at 2.22% in Q1 2026, 20.89% in Q4 2025, and 25.62% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 10.45%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 43.35%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 23.53%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Mimedx 615.09 Mn 455.31 Mn 41.62 Mn 2.22%

Historic Data

Download Data
DateValue
Mar 31, 2026 2.22%
Dec 31, 2025 20.89%
Sep 30, 2025 25.62%
Jun 30, 2025 14.44%
Mar 31, 2025 5.58%
Dec 31, 2024 19.93%
Sep 30, 2024 24.25%
Jun 30, 2024 24.89%
Mar 31, 2024 5.71%
Dec 31, 2023 -1.01%
Sep 30, 2023 17.17%
Jun 30, 2023 13.58%
Mar 31, 2023 0.84%
Dec 31, 2022 4.88%
Sep 30, 2022 0.90%
Jun 30, 2022 -5.06%
Mar 31, 2022 -17.56%
Dec 31, 2021 -22.53%
Sep 30, 2021 9.17%
Jun 30, 2021 1.75%